BioRestorative Therapies Inc., a fully integrated regenerative medicine company, has released an investor presentation detailing its ongoing projects and leadership team. The presentation highlights the company's focus on developing stem cell-based therapies, including brown adipose-derived stem cells and bone marrow-derived mesenchymal stem cells. These initiatives are in various stages, from preclinical to mid-stage clinical development. The presentation also outlines the company's work on Secretome, a biologics-based technology for cosmetic applications. Lance Alstodt serves as the Chairman and CEO, while Francisco Silva is the Vice President of R&D, bringing extensive experience in stem cell research and development. You can access the full presentation through the link below.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.